Allergic Reactions: While uncommon, some individuals may experience allergic reactions to the injection, which can include itching, rash, or difficulty breathing
Conclusion: Tirzepatide presents itself as a promising therapeutic option for the treatment of type 2 diabetes, surpassing Semaglutide in terms of efficacy in glycemic control and weight reduction
No products New product Warning: Last items in stock
1 ee Two-sided P value for the test of no difference
FDA prescribing information recommends healthcare providers consider alternative therapies for patients with prior pancreatitis, as semaglutide has not been adequately studied in this population
Oral options might increase their willingness to initiate and adhere to treatment, potentially broadening the pool of people who can benefit from [GLP-1] therapy. Maintenance therapy after weight loss For people whove already lost weight with an injectable GLP-1, switching to a pill may help maintain progress without continuing injections